Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist

A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 micro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biology of reproduction 1996-07, Vol.55 (1), p.68-74
Hauptverfasser: Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.), Campbell, B.K, Bramley, T.A, Gutierrez, C.G, Peters, A.R, Webb, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 74
container_issue 1
container_start_page 68
container_title Biology of reproduction
container_volume 55
creator Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)
Campbell, B.K
Bramley, T.A
Gutierrez, C.G
Peters, A.R
Webb, R
description A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom
doi_str_mv 10.1095/biolreprod55.1.68
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78314353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78314353</sourcerecordid><originalsourceid>FETCH-LOGICAL-f283t-f4cb21a6aba55d91db57d244e303ce4082adce310ca2fd49ff0952de849f0f93</originalsourceid><addsrcrecordid>eNpVkc1u1TAQhS0EKpfCA4CE5AViRS52HOdnWVVAkSqxaFlHk3h8Y-TYwXYatc_Hg-HSqwKrGZ3z6Yx1TMhrzvacdfLjYLwNuASvpNzzfd0-ITsuy65oyrp9SnaMsboQohbPyYsYfzDGK1GKE3LSNp1gNduRX1frsgSM0XhHjaNpQhpxDJjuBa-p9taa0WIRk5lXC8m4A518mL1DCk5RuyY0ztz9o3_4Y_gbCAbcYwJVeIPWLzO6dH9qQqMxRDp6l0NXv0Z7m3W9RlR0M2miQA_egfIp-MW4IqBFiP_dz76J6SV5psFGfHWcp-T686fr84vi8tuXr-dnl4UuW5EKXY1DyaGGAaRUHVeDbFRZVSiYGLFibQlqRMHZCKVWVad17rhU2OaV6U6ckvcPsbnwnyvG1M8mjmgtOMyv75tW5H6lyODbI7gOM6p-CWaGcNsfW8_-u6MPcQSrA7jRxEdM8FpUbfMXm8xh2kzAPs5gbQ4V_bZtUva8r9uMvXnANPgeDiEnfb_qmvzXnIvfGRevwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78314353</pqid></control><display><type>article</type><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</creator><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</creatorcontrib><description>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</description><identifier>ISSN: 0006-3363</identifier><identifier>EISSN: 1529-7268</identifier><identifier>DOI: 10.1095/biolreprod55.1.68</identifier><identifier>PMID: 8793060</identifier><identifier>CODEN: BIREBV</identifier><language>eng</language><publisher>Madison, WI: Society for the Study of Reproduction</publisher><subject>AGONISTAS ; AGONISTE ; Animals ; Biological and medical sciences ; Buserelin - administration &amp; dosage ; Buserelin - pharmacology ; Cattle ; CICLO ESTRAL ; CYCLE OESTRAL ; Drug Implants ; Female ; Follicle Stimulating Hormone - metabolism ; FSH ; Fundamental and applied biological sciences. Psychology ; GENISSE ; GONADOLIBERINE ; HFS ; HORMONA LIBERADORA DE GONADOTROPINA ; HORMONAS ; HORMONE ; Hormone metabolism and regulation ; INHIBICION ; INHIBITION ; Luteinizing Hormone - metabolism ; Mammalian female genital system ; NOVILLA ; OVAIRE ; Ovarian Follicle - drug effects ; Ovarian Follicle - growth &amp; development ; OVARIOS ; OVULACION ; OVULATION ; Ovulation - drug effects ; PROGESTERONA ; PROGESTERONE ; Progesterone - blood ; SECRECION ; SECRETION ; SERUM SANGUIN ; SUERO SANGUINEO ; Vertebrates: reproduction</subject><ispartof>Biology of reproduction, 1996-07, Vol.55 (1), p.68-74</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3163487$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8793060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creatorcontrib><creatorcontrib>Campbell, B.K</creatorcontrib><creatorcontrib>Bramley, T.A</creatorcontrib><creatorcontrib>Gutierrez, C.G</creatorcontrib><creatorcontrib>Peters, A.R</creatorcontrib><creatorcontrib>Webb, R</creatorcontrib><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><title>Biology of reproduction</title><addtitle>Biol Reprod</addtitle><description>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</description><subject>AGONISTAS</subject><subject>AGONISTE</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Buserelin - administration &amp; dosage</subject><subject>Buserelin - pharmacology</subject><subject>Cattle</subject><subject>CICLO ESTRAL</subject><subject>CYCLE OESTRAL</subject><subject>Drug Implants</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - metabolism</subject><subject>FSH</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GENISSE</subject><subject>GONADOLIBERINE</subject><subject>HFS</subject><subject>HORMONA LIBERADORA DE GONADOTROPINA</subject><subject>HORMONAS</subject><subject>HORMONE</subject><subject>Hormone metabolism and regulation</subject><subject>INHIBICION</subject><subject>INHIBITION</subject><subject>Luteinizing Hormone - metabolism</subject><subject>Mammalian female genital system</subject><subject>NOVILLA</subject><subject>OVAIRE</subject><subject>Ovarian Follicle - drug effects</subject><subject>Ovarian Follicle - growth &amp; development</subject><subject>OVARIOS</subject><subject>OVULACION</subject><subject>OVULATION</subject><subject>Ovulation - drug effects</subject><subject>PROGESTERONA</subject><subject>PROGESTERONE</subject><subject>Progesterone - blood</subject><subject>SECRECION</subject><subject>SECRETION</subject><subject>SERUM SANGUIN</subject><subject>SUERO SANGUINEO</subject><subject>Vertebrates: reproduction</subject><issn>0006-3363</issn><issn>1529-7268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc1u1TAQhS0EKpfCA4CE5AViRS52HOdnWVVAkSqxaFlHk3h8Y-TYwXYatc_Hg-HSqwKrGZ3z6Yx1TMhrzvacdfLjYLwNuASvpNzzfd0-ITsuy65oyrp9SnaMsboQohbPyYsYfzDGK1GKE3LSNp1gNduRX1frsgSM0XhHjaNpQhpxDJjuBa-p9taa0WIRk5lXC8m4A518mL1DCk5RuyY0ztz9o3_4Y_gbCAbcYwJVeIPWLzO6dH9qQqMxRDp6l0NXv0Z7m3W9RlR0M2miQA_egfIp-MW4IqBFiP_dz76J6SV5psFGfHWcp-T686fr84vi8tuXr-dnl4UuW5EKXY1DyaGGAaRUHVeDbFRZVSiYGLFibQlqRMHZCKVWVad17rhU2OaV6U6ckvcPsbnwnyvG1M8mjmgtOMyv75tW5H6lyODbI7gOM6p-CWaGcNsfW8_-u6MPcQSrA7jRxEdM8FpUbfMXm8xh2kzAPs5gbQ4V_bZtUva8r9uMvXnANPgeDiEnfb_qmvzXnIvfGRevwA</recordid><startdate>19960701</startdate><enddate>19960701</enddate><creator>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creator><creator>Campbell, B.K</creator><creator>Bramley, T.A</creator><creator>Gutierrez, C.G</creator><creator>Peters, A.R</creator><creator>Webb, R</creator><general>Society for the Study of Reproduction</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19960701</creationdate><title>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</title><author>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.) ; Campbell, B.K ; Bramley, T.A ; Gutierrez, C.G ; Peters, A.R ; Webb, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-f283t-f4cb21a6aba55d91db57d244e303ce4082adce310ca2fd49ff0952de849f0f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>AGONISTAS</topic><topic>AGONISTE</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Buserelin - administration &amp; dosage</topic><topic>Buserelin - pharmacology</topic><topic>Cattle</topic><topic>CICLO ESTRAL</topic><topic>CYCLE OESTRAL</topic><topic>Drug Implants</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - metabolism</topic><topic>FSH</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GENISSE</topic><topic>GONADOLIBERINE</topic><topic>HFS</topic><topic>HORMONA LIBERADORA DE GONADOTROPINA</topic><topic>HORMONAS</topic><topic>HORMONE</topic><topic>Hormone metabolism and regulation</topic><topic>INHIBICION</topic><topic>INHIBITION</topic><topic>Luteinizing Hormone - metabolism</topic><topic>Mammalian female genital system</topic><topic>NOVILLA</topic><topic>OVAIRE</topic><topic>Ovarian Follicle - drug effects</topic><topic>Ovarian Follicle - growth &amp; development</topic><topic>OVARIOS</topic><topic>OVULACION</topic><topic>OVULATION</topic><topic>Ovulation - drug effects</topic><topic>PROGESTERONA</topic><topic>PROGESTERONE</topic><topic>Progesterone - blood</topic><topic>SECRECION</topic><topic>SECRETION</topic><topic>SERUM SANGUIN</topic><topic>SUERO SANGUINEO</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</creatorcontrib><creatorcontrib>Campbell, B.K</creatorcontrib><creatorcontrib>Bramley, T.A</creatorcontrib><creatorcontrib>Gutierrez, C.G</creatorcontrib><creatorcontrib>Peters, A.R</creatorcontrib><creatorcontrib>Webb, R</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of reproduction</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gong, J.G. (Roslin Institute, Edinburgh, Roslin, Midlothian, UK.)</au><au>Campbell, B.K</au><au>Bramley, T.A</au><au>Gutierrez, C.G</au><au>Peters, A.R</au><au>Webb, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist</atitle><jtitle>Biology of reproduction</jtitle><addtitle>Biol Reprod</addtitle><date>1996-07-01</date><risdate>1996</risdate><volume>55</volume><issue>1</issue><spage>68</spage><epage>74</epage><pages>68-74</pages><issn>0006-3363</issn><eissn>1529-7268</eissn><coden>BIREBV</coden><abstract>A novel experimental model was developed in cattle to investigate the requirement for FSH and LH during ovarian follicle growth and development. On Day 5 of the estrous cycle, 7 heifers were each implanted with an osmotic minipump containing a GnRH agonist (GnRHa), Buserelin (release rate, 2.5 microgram/h). Another 7 heifers served as controls. Each minipump was replaced 28 days later with a second pump, which was left in place for a further 20 days. Blood samples were collected daily throughout the experimental period, and frequent samples were also collected on both days of minipump insertion and at 10 days after insertion of the second pump. The ovaries of all heifers were scanned daily by real-time ultrasonography to monitor follicular dynamics. All controls displayed 2 or 3 waves of FSH and follicular development per estrous cycle during the experiment. Insertion of the first minipump produced a large LH and FSH surge and induced ovulation in all 7 animals. Within 8 days of the start of treatment, serum LH concentrations fell to basal levels; they then remained constant at this level throughout the infusion period, only beginning to recover 4-5 days after the termination of infusion. After the initial increase, FSH returned to basal levels before showing a normal wave that was coincident with the emergence, growth, and regression of a dominant follicle. However, despite the peak levels of FSH, dominant follicles from the next wave failed to grow beyond 7-9 mm; they remained at this size for 3 wk until 3-4 days after insertion of the second minipump, when FSH fell precipitously to reach low levels that were maintained throughout the remainder of the infusion. After this fall in FSH concentrations, these follicles regressed rapidly, and no antral follicles 4 mm were detected until after the termination of treatment. Thereafter, FSH concentrations increased significantly; the increase was accompanied by the emergence of a follicular wave and development of a dom</abstract><cop>Madison, WI</cop><pub>Society for the Study of Reproduction</pub><pmid>8793060</pmid><doi>10.1095/biolreprod55.1.68</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3363
ispartof Biology of reproduction, 1996-07, Vol.55 (1), p.68-74
issn 0006-3363
1529-7268
language eng
recordid cdi_proquest_miscellaneous_78314353
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects AGONISTAS
AGONISTE
Animals
Biological and medical sciences
Buserelin - administration & dosage
Buserelin - pharmacology
Cattle
CICLO ESTRAL
CYCLE OESTRAL
Drug Implants
Female
Follicle Stimulating Hormone - metabolism
FSH
Fundamental and applied biological sciences. Psychology
GENISSE
GONADOLIBERINE
HFS
HORMONA LIBERADORA DE GONADOTROPINA
HORMONAS
HORMONE
Hormone metabolism and regulation
INHIBICION
INHIBITION
Luteinizing Hormone - metabolism
Mammalian female genital system
NOVILLA
OVAIRE
Ovarian Follicle - drug effects
Ovarian Follicle - growth & development
OVARIOS
OVULACION
OVULATION
Ovulation - drug effects
PROGESTERONA
PROGESTERONE
Progesterone - blood
SECRECION
SECRETION
SERUM SANGUIN
SUERO SANGUINEO
Vertebrates: reproduction
title Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A32%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20in%20the%20secretion%20of%20follicle-stimulating%20hormone%20and%20luteinizing%20hormone,%20and%20ovarian%20follicle%20development%20in%20heifers%20continuously%20infused%20with%20a%20gonadotropin-releasing%20hormone%20agonist&rft.jtitle=Biology%20of%20reproduction&rft.au=Gong,%20J.G.%20(Roslin%20Institute,%20Edinburgh,%20Roslin,%20Midlothian,%20UK.)&rft.date=1996-07-01&rft.volume=55&rft.issue=1&rft.spage=68&rft.epage=74&rft.pages=68-74&rft.issn=0006-3363&rft.eissn=1529-7268&rft.coden=BIREBV&rft_id=info:doi/10.1095/biolreprod55.1.68&rft_dat=%3Cproquest_pubme%3E78314353%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78314353&rft_id=info:pmid/8793060&rfr_iscdi=true